There is significant evidence about the redox sensor role of PGC-1α, and mitochondrial ROS may control PGC-1α expression, thus linking it tightly to NAFLD pathogenesis [40]. The gene discussed is PPARGC1A; the disease is metabolic dysfunction-associated steatotic liver disease.